EPO Berlin-Buch GmbH
About
EPO is a preclinical contract research organization (CRO) offering customized pre-clinical oncology and immuno-oncology services for the development of novel anti-cancer drugs.
Our portfolio includes >1000 well characterized PDX models, cell line-derived xenograft- as well as syngeneic tumor models. EPO also has long term experience in the establishment of humanized models and has been running studies in these for over a decade.
EPO has been founded in 1997 as a spin-off from the MDC in Berlin-Buch.
Disease Area
Biomedical Research, Medicine, Human Health
Technology
Representatives
Head of Business Development
EPO Berlin-Buch GmbH
Data Scientist (Life Sciences)
EPO Berlin-Buch GmbH
Chief Scientific Officer (CSO)
EPO Berlin-Buch GmbH